Compounds > adenosine diphosphate ribose

adenosine diphosphate ribose and olaparib

adenosine diphosphate ribose has been researched along with olaparib in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Du, L; He, N; Ji, K; Kong, Y; Liu, Q; Liu, Y; Sun, H; Sun, X; Wang, J; Wang, Q; Wang, Y; Xu, C; Zhang, M; Zhao, X1
Hirota, K; Ibrahim, MA; Masutani, M; Ooka, M; Sasanuma, H; Shimizu, N; Takeda, S; Tsuda, M; Yamada, K; Yamada, S1
Chen, SC; Lai, YH; Tung, KC1

Other Studies

3 other study(ies) available for adenosine diphosphate ribose and olaparib

ArticleYear
BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair.
    Cancer biology & medicine, 2021, 12-01, Volume: 19, Issue:8

    Topics: Adenosine Diphosphate Ribose; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Lung Neoplasms; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Radiation Tolerance; Radiation-Sensitizing Agents; Recombinational DNA Repair; RecQ Helicases

2021
XRCC1 counteracts poly(ADP ribose)polymerase (PARP) poisons, olaparib and talazoparib, and a clinical alkylating agent, temozolomide, by promoting the removal of trapped PARP1 from broken DNA.
    Genes to cells : devoted to molecular & cellular mechanisms, 2022, Volume: 27, Issue:5

    Topics: Adenosine Diphosphate Ribose; Alkylating Agents; DNA; DNA Damage; DNA Repair; Methyl Methanesulfonate; Phthalazines; Piperazines; Poisons; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Temozolomide

2022
Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case report.
    Medicine, 2022, Sep-30, Volume: 101, Issue:39

    Topics: Adenosine Diphosphate Ribose; Adult; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cisplatin; Fanconi Anemia Complementation Group A Protein; Female; Humans; Liver Neoplasms; Male; Mutation; Phthalazines; Piperazines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors

2022